This HTML5 document contains 183 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33436083
rdf:type
wikibase:Item
schema:description
artículo científico publicado en 2016 vedecký článok 2016年论文 wissenschaftlicher Artikel tudományos cikk wetenschappelijk artikel vitskapeleg artikkel vetenskaplig artikel 2016年論文 scienca artikolo 2016年论文 bilimsel makale επιστημονικό άρθρο vitenskapelig artikkel artikull shkencor naučni članak article scientific مقالة علمية videnskabelig artikel (udgivet 2016) scientific article 2016年论文 научна статия บทความทางวิทยาศาสตร์ 2016年の論文 2016年論文 artigo científico (publicado na 2016) teaduslik artikkel 2016年论文 vědecký článek научни чланак mokslinis straipsnis articolo scientifico 2016年論文 2016년 논문 2016 nî lūn-bûn bài báo khoa học artigo científico (publicado na 2016) 2016年论文 articol științific سائنسی مضمون artikulong pang-agham 2016年論文 научни чланак 2016年论文 מאמר מדעי مقالهٔ علمی наукова стаття, опублікована в жовтні 2016 мақолаи илмӣ 2016 թվականի հոտեմբերին հրատարակված գիտական հոդված article científic artykuł naukowy научная статья мақолаи илмӣ 2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ სამეცნიერო სტატია artículu científicu espublizáu en 2016 article scientifique (publié 2016) tieteellinen artikkeli artigo científico 2016年論文
p:P577
wds:Q33436083-2044ABED-72CA-446A-A0FA-84E449B10451
wdt:P577
2016-10-14T00:00:00Z
p:P2860
wds:Q33436083-9C03B6CB-E7D8-4BD4-B7B2-223D92E337BF wds:Q33436083-B8FC40D7-E050-4FC7-A48B-E10D9E5605A1 wds:Q33436083-C0083414-EC94-45F1-BFDD-B85882CD3EBC wds:Q33436083-FDA43682-2768-4A72-882C-18B7C5351E58 wds:Q33436083-FEDC7D37-679C-4FFA-A064-398F9641AB09 wds:Q33436083-DB93CF83-3BEB-42CD-909E-EAED7FFBDF56 wds:Q33436083-35D37A8C-8BE6-42B5-8C71-053A1AEB2019 wds:Q33436083-0EFB2222-1F15-42AE-A9A8-1242D9C083F5 wds:Q33436083-263FA289-3AC3-48C9-8683-F98768ADF625 wds:Q33436083-61B0B2A4-AB39-4DE7-A639-848DF33A0559 wds:Q33436083-3D4A191F-4A84-4615-8F2F-D3EADA54A456 wds:Q33436083-4238D203-E12E-4106-B519-F50FF42DDAE4 wds:Q33436083-45B8284D-AF51-402A-A98B-B491AC8024B7 wds:Q33436083-6FCCA01B-D3D1-4E73-A52E-C15518FA35C2 wds:Q33436083-7458BD61-0EB9-41B5-8B38-F6C53231E927 wds:Q33436083-63B8BC51-5F19-47B3-AE28-706564AD98C0 wds:Q33436083-63FA76D2-C51F-4EFD-9094-C1CFE7EA7487 wds:Q33436083-76C4BECF-A3F7-40F2-B20C-F09685C100A4 wds:Q33436083-7DCBDF60-72A0-41D4-A9BC-66FEC4C29576 wds:Q33436083-82158A65-642E-46F3-8FBB-9079C6359E7B wds:Q33436083-8E10377E-B96B-4F60-AFF3-60EE1BBA01D0 wds:Q33436083-75152F17-28D6-438E-AC65-D49B5B17BAA4 wds:Q33436083-756D005D-3511-48C7-BD92-E2E519EF37BD
wdt:P2860
wd:Q50607902 wd:Q46215379 wd:Q53157941 wd:Q27860881 wd:Q27851712 wd:Q27853158 wd:Q53584979 wd:Q38845158 wd:Q27853013 wd:Q27852408 wd:Q27851394 wd:Q27852116 wd:Q50703777 wd:Q34663877 wd:Q34762839 wd:Q34694358 wd:Q44886865 wd:Q34177532 wd:Q53316003 wd:Q34263959 wd:Q40754073 wd:Q37022191 wd:Q36627196
p:P2093
wds:Q33436083-E23CC022-4A78-4EBD-BBDB-35059BAFA5FE wds:Q33436083-FF7D5D05-7EF4-4543-A266-0733DF1352C2 wds:Q33436083-93D353AA-8AE9-457C-8369-7359F281A1A1 wds:Q33436083-9948D5B0-AFFA-4FE8-932A-0A0B86DDF464 wds:Q33436083-9318E36E-37E1-4DBA-96BF-EEBB1DFA74A8 wds:Q33436083-9EC09EDF-0919-417C-89F6-E0A5D08F1E96 wds:Q33436083-A1024824-3CFB-4DE1-9611-787DA3ADB670 wds:Q33436083-9E308854-656E-40B3-9F21-BCEC5EF5D11F wds:Q33436083-B38D8281-5D04-4EE0-B1BB-D57153CB599F wds:Q33436083-B72514FA-B974-4F01-A983-4F3B0095A92C wds:Q33436083-A8267BBD-8969-4289-A49B-398735CD5C6B wds:Q33436083-6910EBE4-5437-403B-9E46-B292EB54E650 wds:Q33436083-638192AE-DA06-4A74-B843-2E6A1C20461A wds:Q33436083-705353A5-76B9-47CA-8AD6-8F8C6A35E137 wds:Q33436083-74D2D33F-65FB-4FCF-88E8-6436ED6D229F wds:Q33436083-1F0E0B16-A081-4BD8-BEFD-E9CDA76017F7 wds:Q33436083-2C37CAA3-40A0-4E7B-8BE1-7EED02E61DFA wds:Q33436083-3938F67E-7533-473C-B949-88A55F55E1EB wds:Q33436083-4E6EEA14-A13C-4B42-9986-88242DCB8671
wdt:P2093
Makoto Nishio Glenwood Goss Frances A Shepherd Frank Dunphy Miyako Satouchi Helen Mann Lyudmila Bazhenova Ji-Youn Han Mireille Cantarini Margarita Majem Chun-Ming Tsai Jin-Hyoung Kang Toyoaki Hida Serban Ghiorghiu Gee-Chen Chang Quincy Chu Lucio Crino Tetsuya Mitsudomi Jong Seok Lee
rdfs:label
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
skos:prefLabel
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
schema:name
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
p:P50
wds:Q33436083-6ABC13BA-BE0E-4241-884C-87B387262A21
wdt:P50
wd:Q56885797
p:P1476
wds:Q33436083-2CAE9313-BF37-42EC-AB0F-6A5B6D3A9AF1
wdt:P1476
Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
p:P304
wds:Q33436083-5E18C159-3572-4B40-8045-DCFD722D7FEA
wdt:P304
1643-1652
p:P31
wds:Q33436083-76A54621-F741-40DA-A9FF-1F03D70E15C9
wdt:P31
wd:Q13442814
p:P921
wds:Q33436083-C4E87B53-C7A4-4229-A640-318A9ECFF10E wds:Q33436083-9166702C-F01A-4154-BC2C-053BD13E2449
wdt:P921
wd:Q6934595 wd:Q47912
p:P698
wds:Q33436083-C6DA45AD-5688-4255-9696-614AE74354B9
wdtn:P698
n10:27751847
wdt:P698
27751847
p:P1433
wds:Q33436083-54F873BA-E2A3-47E3-9FFC-71F17F310893
wdt:P1433
wd:Q13747613
p:P433
wds:Q33436083-E63D0855-EF6A-4020-97EE-D48522308274
p:P478
wds:Q33436083-AB6FEB27-1330-4B36-BF82-BC52CB13835F
wdt:P433
12
wdt:P478
17
p:P356
wds:Q33436083-F54F7D06-4857-406B-B4F7-D08125201B03
wdtn:P356
n11:S1470-2045(16)30508-3
wdt:P356
10.1016/S1470-2045(16)30508-3
p:P8608
wds:Q33436083-266AEC21-50DD-4282-9E29-884F36BF7150
wdt:P8608
release_jt4iyonlzzarfikkk7trfw5w6a